Cancer Research Horizons Biomarkers Summit

Learn about our new 5-letter sequencing technology – duet multiomics solution +modC – and discover the combinatorial power of genetics and epigenetics.
17 November 2023
to 17 November 2023
Cancer Research UK Centre
, Manchester

Visit biomodal at booth 

#NA

About the event

The purpose of this Biomarkers Commercialisation Summit is to support researchers of the CRUK Biomarker Centre and the Manchester Cancer Research Centre to explore pathways to translate their biomarkers and diagnostics research towards clinical use and market adoption.   

Presenting at the event

Considerations for Commercialising Multimodal Diagnostics

Paidi Creed

Senior Director, Computational Technologies

biomodal

11.45am - 12.15pm

Review specific considerations for multimodal software-based diagnostics.

Panel Discussion: Taking a Diagnostic to Market - Industry Perspective

Paidi Creed

Senior Director, Computational Technologies

biomodal

3.00pm - 3.45pm

The aim of this panel is to provide practical insights for researchers considering or already engaged in research translation and technology licensing, highlighting the opportunities and challenges associated with this path.

Find the venue

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

Attending from biomodal

Páidí Creed
Vice President, Computational Technologies

Register now

Cancer Research Horizons Biomarkers Summit 17Nov23

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

Cambridge Epigenetix is now biomodal